HomeInsightsStock Comparison

Aurobindo Pharma Ltd vs Kabra Drugs Ltd Stock Comparison

Aurobindo Pharma Ltd vs Kabra Drugs Ltd Stock Comparison

Last Updated on: May 06, 2025

Key Highlights

  • The Latest Trading Price of Aurobindo Pharma Ltd is ₹ 1189 as of 06 May 09:20.
  • The P/E Ratio of Aurobindo Pharma Ltd changed from 8.5 on March 2020 to 20.1 on March 2024 . This represents a CAGR of 18.78% over 5 yearsThe P/E Ratio of Kabra Drugs Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Aurobindo Pharma Ltd changed from ₹ 24202 crore on March 2020 to ₹ 63835 crore on March 2024 . This represents a CAGR of 21.41% over 5 yearsThe Market Cap of Kabra Drugs Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Aurobindo Pharma Ltd for the Dec '24 is ₹ 8137 crore as compare to the Sep '24 revenue of ₹ 7932 crore. This represent the growth of 2.58% The revenue of Kabra Drugs Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Aurobindo Pharma Ltd for the Dec '24 is ₹ 1736 crore as compare to the Sep '24 ebitda of ₹ 1702 crore. This represent the growth of 2.02% The ebitda of Kabra Drugs Ltd for the Dec '24 is ₹ 0 crore as compare to the Sep '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Aurobindo Pharma Ltd changed from ₹ 569.71 crore to ₹ 845.57 crore over 7 quarters. This represents a CAGR of 25.31% The net profit of Kabra Drugs Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Aurobindo Pharma Ltd changed from 9.37 % on March 2020 to 13.49 % on March 2024 . This represents a CAGR of 7.56% over 5 yearsThe Dividend Payout of Kabra Drugs Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Aurobindo Pharma Ltd

  • Aurobindo Pharma Limited (APL), one of the world's top 5 manufacturers of semi synthetic penicillins was incorporated in 26th December 1986 as a private limited company.
  • Mr. P.V.Ramaprasad Reddy, Mr. K.Nityananda Reddy and a small, highly committed group of professionals founded it.
  • APL is developing, manufacturing and marketing active pharmaceutical ingredients (APIs also referred as bulk actives), intermediates and generic formulations.
  • The company's robust product portfolio is spread over 6 major product areas encompassing (Antibiotics, Anti-Retro Virals, CVS, CNS, Gastroenterologicals, and Anti-Allergics) with around 65 APIs in the non-antibiotics and over 55 APIs in the antibiotic segment and the World Health Organization (WHO), Geneva, has also approved Aurobindo's products.
  • APL is running with 24 manufacturing plants across the world conforming to GMP/ISO regulations and an extremely well equipped 9 R&D facilities.

About Kabra Drugs Ltd

  • Kabra Drugs Ltd was incorporated as a Limited Company on August 22, 1989.
  • The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical.
  • The commercial production commenced in 1991.
  • Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products. The latest addition to the product line is the range of disinfectants which includes hand wash gel, hand sanitizer and antimicrobial gel.
  • In India there are very few manufacturers who are manufacturing the said products.

Aurobindo Pharma Ltd News Hub

News

Aurobindo Pharma drops after fire incident at Kakinada facility

The incident, which occurred on 27 April 2025, has prompted a temporary suspension of oper...

Read more

29 Apr 2025 16:22

News

CuraTeQ Biologics s.r.o. receives positive opinion for biosimilar Dazublys' from EMA

CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma, announc...

Read more

26 Apr 2025 13:58

News

Aurobindo Pharma rallies after arm receives USFDA nod for Dasatinib tablets

The drug is bioequivalent and therapeutically equivalent to the reference listed drug (RLD...

Read more

23 Apr 2025 12:05

News

Aurobindo Pharma rallies after receiving USFDA nod for Rivaroxaban tablets

The said drug is bioequivalent and therapeutically equivalent to the reference listed drug...

Read more

15 Apr 2025 10:07

News

Aurobindo Pharma gets USFDA nod for Rivaroxaban tablets

The said drug is bioequivalent and therapeutically equivalent to the reference listed drug...

Read more

14 Apr 2025 08:59

News

USFDA inspects Aurobindo Pharma's Raleigh Plant in North Carolina

Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) has...

Read more

11 Apr 2025 15:22

Kabra Drugs Ltd News Hub

News

Kabra Drugs to conduct board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 February 20...

Read more

08 Feb 2025 11:03

News

Kabra Drugs to conduct EGM

Kabra Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be ...

Read more

05 Dec 2024 17:27

News

Kabra Drugs schedules board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 December 202...

Read more

26 Nov 2024 09:56

News

Kabra Drugs to convene board meeting

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 14 November 20...

Read more

08 Nov 2024 12:27

News

Kabra Drugs to consider Fund Raising

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 4 November 202...

Read more

22 Oct 2024 11:01

News

Kabra Drugs to hold AGM

Kabra Drugs announced that the 35th Annual General Meeting (AGM) of the company will be he...

Read more

16 Sep 2024 09:56

SWOT Analysis Of Aurobindo Pharma Ltd

Strength

3

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Aurobindo Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Kabra Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Aurobindo Pharma Ltd and Kabra Drugs Ltd

Which company has a larger market capitalization, Aurobindo Pharma Ltd or Kabra Drugs Ltd?

Market cap of Aurobindo Pharma Ltd is 72,814 Cr while Market cap of Kabra Drugs Ltd is 26 Cr

What are the key factors driving the stock performance of Aurobindo Pharma Ltd and Kabra Drugs Ltd?

The stock performance of Aurobindo Pharma Ltd and Kabra Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aurobindo Pharma Ltd and Kabra Drugs Ltd?

As of May 6, 2025, the Aurobindo Pharma Ltd stock price is INR ₹1242.7. On the other hand, Kabra Drugs Ltd stock price is INR ₹11.08.

How do dividend payouts of Aurobindo Pharma Ltd and Kabra Drugs Ltd compare?

To compare the dividend payouts of Aurobindo Pharma Ltd and Kabra Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions